Sanofi, Kweichow Moutai, Microsoft: Intellectual Property

A patent dispute between Actavis Group HF and Paris-based Sanofi over a drug to treat diabetes and hypertension was referred to a European Union court by a London judge.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.